Insulin Resistance As A Drug Target Flashcards
Risk factors of T2 diabetes?
Older age
Ethnicity
Hypertension
Family history
Obesity
Increased alcohol intake
Smoking
Polycystic ovarian syndrome
Antipsychotic medication
Steroids
Clinical features/symptoms of diabetes and persistent hyperglycaemia I.e
HbA1c 48 mol/mol or more
Fasting plasma glucose 7 mmol/L or more
Random plasma glucose 11.1 mmol/L or more
Plasma glucose of 11.1mmol/L or more 2 hours after OGTT
IF PATIENT ASYMPTOMATIC
2X fasting plasma glucose samples >7mmol/L
Insulin resistance
Where the body is unable to respond to normal levels of insulin
Relative insulin deficiency
Where the pancreas is unable to secrete enough insulin to compensate for this resistance
T2 diabetes caused by combination of?
Insulin resistance and relative insulin deficiency
Pre-diabetes may refer to?
Impaired fasting glucose
Impaired glucose tolerance
Impaired fasting glucose
Higher than normal blood glucose after a period of fasting
Impaired glucose tolerance
Higher than normal blood glucose after eating or OGTT
Why is pre-diabetes: impaired fasting glucose (IFG) and impaired glucose tolerance ( IGT) important
They are considered to be a stage of development of T2 diabetes and a risk factor of CVD
GESTATIONAL diabetes
A degree of glucose intolerance with onset (or first diagnosis) during pregnancy and usually resolving shortly after delivery
Hormones secreted by the placenta during pregnancy increase or decrease insulin resistance?
Increase
During pregnancy, post-grandial glucose conc. increase as insulin resistance increase
Managing T2 diabetes
Adult with T2 diabetes
Lifestyle interventions + dietary control
Consider mono therapy
Consider dual therapy
Consider triple therapy/ consider insulin programme
Examples of diabetic drug
Metformin
Sulphonylureas
GLP-1 agonists
DPP4 inhibitors
SGLT-2 inhibitors
Thiazolidinediones
Examples of Sulphonylureas and mechanism
Gliclazide
Mechanism= stimulates pancreatic insulin secretion by blocking K+ channels in pancreatic beta cells
GLP-1 agonists: example and mechanism of action
Exenatide/ Liraglutide
Mechanism = increases insulin secretion from beta cells after meals + suppresses glucagon release + reduces gastric emptying, increases satiety
GLP-1 meaning
Glucagon like peptide 1
DPP4 inhibitors :example and mechanism of action
Sitagliptin , linagliptin
Delays inactivation of GLP-1
SGLT-2 inhibitors: example and mechanism of action
Dapagliflozin
Mech= inhibits renal absorption of glucose
Thiazolidinediones: example and mechanism of action
Enhances insulin action= increased peripheral glucose uptake + gluconeogenesis
Diabetic drug that has an advantage of weight loss
Metformin,
GLP-1 inhibitors (consider use if BMI > 35)
, SGLT-2 inhibitors ( CAN improve BP)
SGLT-2 stands for?
Sodium-glucose co- transporter-2